Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical    ISRG

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Intuitive Surgical, Inc. : Hagens Berman Notifies Investors of June 25, 2013, Lead Plaintiff Deadline in Intuitive Surgical, Inc. Securities Class Action

share with twitter share with LinkedIn share with facebook
share via e-mail
04/29/2013 | 03:30pm CET

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today notified investors of a pending June 25, 2013, deadline to file for lead plaintiff in a securities class-action lawsuit brought again Intuitive Surgical, Inc. (NASDAQ: ISRG) ("ISRG" or "the company"). The firm encourages investors with more than $500,000 in losses to contact Hagens Berman Partner Reed Kathrein to discuss moving for lead plaintiff by emailing [email protected] or calling (510) 725-3000.

Investors who purchased ISRG common stock between Oct. 19, 2011, and April 18, 2013, (the "class period") and have more than $500,000 in losses can also reach an attorney by visiting http://www.hb-securities.com/investigations/ISRG.

The lawsuit, filed in U.S. District Court for the Northern District of California on April 26, 2013, alleges that ISRG issued a series of false or misleading statements to investors during the class period. The suit alleges that ISRG failed to fully disclose to investors the financial impact of safety problems with its da Vinci Surgical System, including a number of deaths allegedly caused by the system.

A number of lawsuits have been filed against the company seeking damages for injuries caused by da Vinci. Following media coverage of those suits, ISRG's stock price suffered a significant decline. The filed investor lawsuit claims that ISRG deceived investors regarding the risk of Food and Drug Administration action against the company.

"We are concerned that ISRG failed to come clean with investors, especially in light of a significant number of deaths reported to the FDA," said Mr. Kathrein. "We are concerned that the company may be exposed to significant financial losses, either due to potential FDA restrictions on da Vinci or damages in pending personal injury lawsuits."

Investors who wish to serve as lead plaintiff in the case must move the court no later than June 25, 2013. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Hagens Berman reminds whistleblowers with inside information that rewards may be available to individuals who report information leading to a successful enforcement action by the Securities and Exchange Commission. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

About Hagens Berman

Hagens Berman Sobol Shapiro LLP is an investor-rights class-action law firm with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the law firm and its successes can be found at www.hbsslaw.com. The Firm's securities law blog is at http://www.meaningfuldisclosure.com.

Firmani + Associates
Mark Firmani, 206-443 9357
[email protected]

© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
11/19 INTUITIVE SURGICAL : Investigational Robotic-assisted Surgical Tool May Be Effec..
11/15 INTUITIVE SURGICAL : MILITARY $20,000 Federal Contract Awarded to Intuitive Surg..
11/07 INTUITIVE SURGICAL : New Study Reports Favorable Results for Intuitive Surgical'..
11/03 INTUITIVE SURGICAL : New Study Reports Favorable Results for Intuitive Surgicals..
11/02 New Study Reports Favorable Results for Intuitive Surgical’s Flexible R..
10/31 INTUITIVE SURGICAL : I , surgeon
10/30 INTUITIVE SURGICAL, INC. (NASDAQ : ISRG) Files An 8-K Departure of Directors or ..
10/27 INTUITIVE SURGICAL INC : Change in Directors or Principal Officers (form 8-K)
10/26 INTUITIVE SURGICAL : Findings from Chinese University of Hong Kong in the Area o..
10/25 INTUITIVE SURGICAL : Earnings Review and Free Research Report: Intuitive Surgica..
More news
News from SeekingAlpha
11/15 YOUR DAILY PHARMA SCOOP : Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA A..
11/14 The Stock Market Cycle And Implications For Medical Stock Investing
11/14 TRANSENTERIX : What European Da Vinci Surgeons Say About The Senhance System
11/13 STRYKER : Growth In 2018
11/03 Own The Bots With These 2 ETFs
Financials ($)
Sales 2017 3 087 M
EBIT 2017 1 269 M
Net income 2017 925 M
Finance 2017 2 984 M
Yield 2017 -
P/E ratio 2017 50,54
P/E ratio 2018 50,66
EV / Sales 2017 13,4x
EV / Sales 2018 11,8x
Capitalization 44 437 M
Duration : Period :
Intuitive Surgical Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Technical analysis trends INTUITIVE SURGICAL
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 374 $
Spread / Average Target -5,7%
EPS Revisions
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Salvatore J. Brogna Chief Operating Officer & Executive Vice President
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER20.45%65 220
ROYAL PHILIPS14.90%37 142
ILLUMINA68.19%31 441